Author

Sanja Mehandziska

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 1 Genetics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Research Focus:drug response / drug discovery· 2 Organism:human· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:gene regulatory network inference· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

Goran KungulovskiiD· 2 shared Ivan KungulovskiiD· 2 shared Aleksandra Stajkovska· 1 shared Djansel BukoveciD· 1 shared Marija GjorgjievskaiD· 1 shared Marija Janevska· 1 shared Martina MarkovskaiD· 1 shared Milan RisteskiiD· 1 shared

Activity by Year

2019-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenetic & Genomic Medicine

Goran KungulovskiORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Tumors with mutations in chromatin regulators are associated with higher mutational burden and improved response to checkpoint immunotherapy

Goran Kungulovski, Marija Gjorgjievska, Sanja Mehandziska, Djansel Bukovec, Milan Risteski, Ivan Kungulovski, Zan Mitrev

This study shows that tumors with chromatin regulator mutations have higher mutational burden and better response to immunotherapy.

medRxiv · Oct 15, 2024 · PreprintGenetic & Genomic Medicine

Genetic aberrations in chromatin factors are pervasive, mutually exclusive, associated with a high mutational burden and improved response to checkpoint immunotherapy in cancer

Martina Markovska, Rodney Alexander Rosalia, Aleksandra Stajkovska, Sanja Mehandziska, Marija Janevska, Ivan Kungulovski, Zan K. Mitrev, Goran Kungulovski

The paper examines genetic aberrations in chromatin modifiers across cancer datasets, finding mutual exclusivity, higher prevalence in certain cancers, and links to mutational burden and immunotherapy response.

bioRxiv · Dec 3, 2019 · PreprintGenetics